Xavier García–Moll

2.4k total citations
83 papers, 1.3k citations indexed

About

Xavier García–Moll is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Xavier García–Moll has authored 83 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Cardiology and Cardiovascular Medicine, 24 papers in Surgery and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Xavier García–Moll's work include Acute Myocardial Infarction Research (22 papers), Antiplatelet Therapy and Cardiovascular Diseases (17 papers) and Cardiac Imaging and Diagnostics (15 papers). Xavier García–Moll is often cited by papers focused on Acute Myocardial Infarction Research (22 papers), Antiplatelet Therapy and Cardiovascular Diseases (17 papers) and Cardiac Imaging and Diagnostics (15 papers). Xavier García–Moll collaborates with scholars based in Spain, United Kingdom and Italy. Xavier García–Moll's co-authors include Juan Carlos Kaski, Emmanouil Zouridakis, Juan Carlos Kaski, Lina Badimón, Fabio Coccolo, Della Cole, José Ramón González‐Juanatey, Juan José Gómez‐Doblas, Juan Cinca and Roberto Ferrari and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Xavier García–Moll

78 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xavier García–Moll Spain 21 647 339 207 191 171 83 1.3k
Manabu Ogita Japan 23 846 1.3× 655 1.9× 225 1.1× 220 1.2× 200 1.2× 98 1.6k
Ryo Naito Japan 24 853 1.3× 676 2.0× 194 0.9× 220 1.2× 218 1.3× 112 1.7k
Ender Örnek Türkiye 19 498 0.8× 303 0.9× 300 1.4× 94 0.5× 209 1.2× 78 1.3k
Matthias Frick Austria 24 728 1.1× 495 1.5× 290 1.4× 176 0.9× 90 0.5× 68 1.8k
Sheng‐Hsiung Sheu Taiwan 23 1.2k 1.8× 543 1.6× 294 1.4× 294 1.5× 197 1.2× 199 2.1k
Akihiro Nakagomi Japan 17 680 1.1× 293 0.9× 179 0.9× 218 1.1× 122 0.7× 36 1.2k
Tse‐Min Lu Taiwan 12 525 0.8× 265 0.8× 206 1.0× 99 0.5× 91 0.5× 56 1.1k
Hideaki Jinnouchi Japan 15 722 1.1× 372 1.1× 130 0.6× 132 0.7× 191 1.1× 40 1.3k
Georgios Chalikias Greece 27 812 1.3× 375 1.1× 336 1.6× 137 0.7× 135 0.8× 85 1.8k
Juan Carlos Kaski United Kingdom 20 718 1.1× 264 0.8× 157 0.8× 375 2.0× 195 1.1× 35 1.3k

Countries citing papers authored by Xavier García–Moll

Since Specialization
Citations

This map shows the geographic impact of Xavier García–Moll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier García–Moll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier García–Moll more than expected).

Fields of papers citing papers by Xavier García–Moll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier García–Moll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier García–Moll. The network helps show where Xavier García–Moll may publish in the future.

Co-authorship network of co-authors of Xavier García–Moll

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier García–Moll. A scholar is included among the top collaborators of Xavier García–Moll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier García–Moll. Xavier García–Moll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Torre-Hernández, José M. de la, Rut Andrea, Miguel Corbí‐Pascual, et al.. (2024). Recomendaciones para la optimización de la atención a los pacientes tras infarto agudo de miocardio. Proyecto MIMIC. REC CardioClinics. 60(2). 127–138.
2.
Conde, Almudena Castro, Juan José Gómez‐Doblas, José Luis Górriz, et al.. (2023). Comprehensive Cardiovascular and Renal Protection in Patients with Type 2 Diabetes. Journal of Clinical Medicine. 12(12). 3925–3925. 9 indexed citations
3.
Garcı́a, Eduardo, Inka Miñambres, Claudia Velásquez, et al.. (2023). Increased sLRP1 and decreased atrial natriuretic peptide plasma levels in newly diagnosed T2DM patients are normalized after optimization of glycemic control. Frontiers in Endocrinology. 14. 1236487–1236487. 1 indexed citations
4.
López, Laura, et al.. (2022). Urinary Proteomic Signature in Acute Decompensated Heart Failure: Advances into Molecular Pathophysiology. International Journal of Molecular Sciences. 23(4). 2344–2344. 5 indexed citations
5.
Koufakis, Theocharis, Омар Мустафа, Ramzi Ajjan, et al.. (2022). From Skepticism to Hope: The Evolving Concept of the Initiation and Use of Sodium-Glucose Cotransporter 2 Inhibitors in Hospitalized Patients. Drugs. 82(9). 949–955. 15 indexed citations
6.
González‐Juanatey, Carlos, Manuel Anguita‐Sánchez, Vivencio Barrios, et al.. (2022). Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural Language Processing. Journal of Clinical Medicine. 11(20). 6004–6004. 8 indexed citations
7.
López, Laura, et al.. (2022). Vitamin D Binding Protein and Renal Injury in Acute Decompensated Heart Failure. Frontiers in Cardiovascular Medicine. 9. 829490–829490. 8 indexed citations
8.
Cequier, Ángel, Vicente Arrarte, Raquel Campuzano, et al.. (2020). Tratamiento hipolipemiante en los pacientes con enfermedad cardiovascular de riesgo muy elevado. Documento de consenso SEC sobre las indicaciones de los iPCSK9 en la práctica clínica. REC CardioClinics. 56(1). 39–48. 2 indexed citations
9.
Koufakis, Theocharis, Омар Мустафа, Ramzi Ajjan, et al.. (2020). The use of sodium‐glucose co‐transporter 2 inhibitors in the inpatient setting: Is the risk worth taking?. Journal of Clinical Pharmacy and Therapeutics. 45(5). 883–891. 26 indexed citations
10.
Hernández, José L., Francisco S. Lozano, Manuel Almendro‐Delia, et al.. (2020). Reducing residual thrombotic risk in patients with peripheral artery disease: impact of the COMPASS trial. Drugs in Context. 9. 1–15. 3 indexed citations
11.
Kalra, Paul R., Xavier García–Moll, Philip A. Kalra, et al.. (2014). Impact of Chronic Kidney Disease on Use of Evidence-Based Therapy in Stable Coronary Artery Disease: A Prospective Analysis of 22,272 Patients. PLoS ONE. 9(7). e102335–e102335. 20 indexed citations
12.
Tziakas, Dimitrios, Georgios Chalikias, Dimitrios Stakos, et al.. (2014). Validation of a New Risk Score to Predict Contrast-Induced Nephropathy After Percutaneous Coronary Intervention. The American Journal of Cardiology. 113(9). 1487–1493. 37 indexed citations
13.
Jiménez‐Quevedo, Pilar, Juan José González‐Ferrer, Manel Sabaté, et al.. (2012). TCT-391 Selected CD133+ endothelial progenitor cells to create angiogenesis in no-option patients. Preliminary results of Safety and feasibility. Journal of the American College of Cardiology. 60(17). B112–B112. 1 indexed citations
14.
García–Moll, Xavier, et al.. (2012). Caso clínico 2: paciente con angina crónica estable y varios factores de riesgo. Diagnóstico, estratificación pronóstica y tratamiento. Revista Española de Cardiología Suplementos. 12. 30–36. 2 indexed citations
15.
Alonso, Joaquín, et al.. (2010). Influence of Sex on Acute Coronary Syndrome Mortality and Treatment in Spain. Revista Española de Cardiología. 8. 8–22. 3 indexed citations
16.
Bayés‐Genís, Antoni, Diego Goldwasser, Anna Kotzeva, et al.. (2008). New electrocardiographic diagnostic criteria for the pathologic R waves in leads V1 and V2 of anatomically lateral myocardial infarction. Journal of Electrocardiology. 41(5). 413–418. 16 indexed citations
17.
Alonso, Joaquín, et al.. (2008). Influencia del sexo en la mortalidad y el manejo del síndrome coronario agudo en España. Revista Española de Cardiología Suplementos. 8(4). 8D–22D. 13 indexed citations
18.
Kaski, Juan Carlos, Pedro L. Sánchez, Daniel Fernández‐Bergés, et al.. (2008). Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome. Atherosclerosis. 201(1). 176–183. 37 indexed citations
19.
20.
Lamich, Rubén, Joan Raimón Gumà, Xavier García–Moll, et al.. (1993). Prospective study of bacteremia during transesophageal echocardiography. American Heart Journal. 125(5). 1454–1455. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manabu Ogita Breakdown of academic impact, for papers by Ryo Naito Breakdown of academic impact, for papers by Ender Örnek Breakdown of academic impact, for papers by Matthias Frick Breakdown of academic impact, for papers by Sheng‐Hsiung Sheu Breakdown of academic impact, for papers by Akihiro Nakagomi Breakdown of academic impact, for papers by Tse‐Min Lu Breakdown of academic impact, for papers by Hideaki Jinnouchi Breakdown of academic impact, for papers by Georgios Chalikias Breakdown of academic impact, for papers by Juan Carlos Kaski
Rankless by CCL
2026